Rating: Neutral | Target Price: RMB 19.1–21.6 (Base-Scenario Fair Range) | Current Price: RMB 20.84 (as of 2026-10-26 close) | Margin of Safety: -8% (base fair-value floor of RMB 19.1 vs. current price of RMB 20.84 — no margin of safety) | Time Horizon: 6–12 months
Market cap RMB 39.53 billion (1,896.64 million total shares) | Sector: Financial IT / Capital Markets Software | Report date: 2026-10-27
Hundsun Technologies is the undisputed leader in China A-share capital markets IT, but it is in the longest revenue contraction since its founding: revenue for FY2024/FY2025/2026H1 declined -9.62%/-12.13%/-11.65% YoY, a cumulative decline of roughly -21% from peak. The apparent resilience of profits (2026H1 net profit attributable +0.06%, adjusted +8.37%) rests on three non-core pillars — expense reduction from a 22% headcount cut over two years, equity-method income from its 24.10% stake in Ant Fund (2026H1 investment income of RMB 328 million already exceeded the period's total profit of RMB 281 million), and active downsizing of low-margin businesses; excluding equity-method income, 2026H1 core-business adjusted profit was roughly -RMB 70 million. The bulls' core thesis (the 2026–2027 Xinchuang core-system replacement window) has leading order signals (UF3.0 signed 25 customers within the year, contract liabilities +15.4% YoY, subscription revenue +14.57%), but contract liabilities fell -2.9% sequentially from the start of the year and the new core market is split among four vendors — the transmission from "orders to positive revenue growth" is not yet closed. On valuation, the current price of RMB 20.84 back-solves to an implied 2026 adjusted profit of roughly RMB 1.13 billion (+11.5%), slightly above the incentive KPI line of +10% and consensus of +10% — pricing is fair to slightly full; the probability-weighted fair value across three scenarios is roughly RMB 21.5 (+3.3% vs. current price), with broadly symmetric odds tilting slightly upward. Conclusion: quality is high, price is fair — neutral/hold; no value for adding until right-side signals appear (a quarter of positive revenue growth, sequential rebound in contract liabilities, confirmation of KPI attainment). Key constraint: if FY2026 adjusted profit falls below the RMB 1.115 billion KPI line or Ant Fund earnings weaken with the market, the valuation anchor will slide from the base 35x toward the bear-case 25x (implying RMB 11.5–13.5).
One-sentence opportunity: The current price already prices in a "KPI-line-level" adjusted-profit recovery; over the next 6–12 months the opportunity is conditional — with the 2026-10-31 Q3 report and the Q4 Xinchuang acceptance season as the right-side switch: confirmation of revenue stabilization opens the bull case of RMB 29.6 (+42%), refutation converges toward the bear case of RMB 12.3 (-41%); evidence grade B, industry environment facing headwinds (total IT budgets of financial institutions under pressure, structural reallocation).
Key changes (from → to):
Primary share-price driver: Adjusted-profit delivery in the Q4 acceptance/recognition season — 90.3% of FY2025 adjusted profit was recognized in Q4; 2026 hinges on Q4 signings and revenue carryover. Leading indicator: contract liability balance in the 10-31 Q3 report (vs. RMB 2.587 billion at end-2026H1 and RMB 2.400 billion at end-2025Q3).
Expectation gap: At the valuation level the gap is small — the current price already prices in "KPI-line-level" recovery (implied +11.5% > H1 actual +8.4%); the real disagreement is on the timing of revenue stabilization: the median sell-side target price of RMB 32.4 (9 houses) implies that most assume stabilization within 2026, while backlog trends support a turnaround only in 2027. Both directions have clearly falsifiable switches.
Dimensional profile: Room for change 2 / driver strength 3 / expectation gap 2 / catalyst density 3.
Excluding equity-method income, 2026H1 core-business adjusted profit was roughly -RMB 70 million (vs. roughly +RMB 97 million in 2025H1) — the true operating state of the core business is weaker than the headline adjusted +8.37%. Gross margin must be read by scope: annual gross margin (main business) fell from 74.85% (FY2023) to 71.06% (FY2025), reflecting deteriorating revenue mix and marginally weaker pricing power; but on a like-for-like basis 2026H1 was only -0.16pct YoY (69.40% vs. 69.56%), showing signs of stabilization at the margin. The reverse scenario in this report is continued bleeding of the core business through 2027; if the Q3 or annual report shows a quarter of positive revenue growth or a return to positive core-business adjusted profit (ex-equity-method income), this thesis is invalidated.
Three gaps lie between the reality of Xinchuang demand and Hundsun's delivery: first, contract liabilities improved YoY but declined sequentially, and revenue recognized from opening contract liabilities this period was RMB 971 million — drawn down faster than replenished — so "orders ramping ahead" cannot yet be confirmed; second, the "25 customers" is a cumulative-within-2026 signing count with no disclosed contract value, and the "over 50 million migrated accounts" includes customers from M&A integration; third, the brokerage new-core market is split among four vendors — Hundsun UF3.0, Apex A5, Kingdom FS2.5, and业内 ATP — with Apex winning CITIC Securities at end-2023 and Kingdom winning a leading brokerage in 2025-10; the company's own semi-annual report states that in this segment "vicious competition has emerged, severely squeezing the profit space of the entire industry." Full-year 2026 revenue is expected to still decline; even if 2027 turns positive, the low-base effect from 2026's active downsizing must be stripped out. Watch points: whether Q3 contract liabilities rebound sequentially, UF3.0 new signings and values within the year, which vendor wins leading-brokerage new-core deals, and whether blended gross margin holds above 67%.
Back-solving market cap at 35x (a ~10% discount to the peer median of 38.9x) implies 2026 adjusted profit of roughly RMB 1.13 billion (+11.5%), slightly above the incentive KPI line (+10%) and 2026H1 actual (+8.4%). An important scope note: both the KPI line and the back-solved figure are total adjusted profit including Ant Fund equity income — if Ant is valued at its 2026 annualized earnings (equity income ~RMB 550 million), the current price implies core-business adjusted profit of only ~RMB 710 million, negative growth vs. FY2025's core RMB 750 million; if Ant is valued at FY2025 earnings (~RMB 5.2 billion), implied core-business adjusted profit is ~RMB 880 million (+17%). In other words, the price paid for the core business sits between "negative growth" and "low-double-digit recovery," with the midpoint right around the KPI line. The probability-weighted fair value across three scenarios (bear 20% / base 50% / bull 30%) is ~RMB 21.5, +3.3% vs. the current price; the base fair-value floor of RMB 19.1 is -8% vs. the current price — no margin of safety. Although PB of 4.07x sits at the 4th percentile of the past 10 years, ROE has fallen from 19% (2023) to 13% (2025); the percentile is reference only, not a headline cheap/expensive signal. With earnings in early stabilization after a downturn, the PE percentile (10% over 10 years) is likewise reference only. The median sell-side target price of RMB 32.4 is ~59% above our base case, with its implied "revenue stabilization within 2026" assumption more optimistic than our 2027 turnaround — this is the main divergence between this report and the sell side.
As of 2026-06-30, cash-like assets were ~RMB 4.04 billion, interest-bearing debt RMB 470 million, net cash ~RMB 3.57 billion (~RMB 1.88/share), with no history of dilutive financing. The 24.10% Ant Fund stake, estimated at 20x, is worth ~RMB 5.2 billion (on FY2025 net profit of RMB 1.085 billion; ~RMB 11.0 billion on 2026 annualized earnings) — but the new fund distribution fee-rate rules took effect 2026-01-01, and Ant's sharp H1 net profit growth partly reflects an equity bull market; this holding is doubly sensitive to fee reform and market cycles, and 20x itself embeds optimistic assumptions. On impairments: goodwill of RMB 620 million is only 1.6% of market cap (in 2025, Hundsun Cloud provisioned RMB 9.97 million and Summit RMB 12.74 million for the first time; FY2024 impairment targets were Jinna/Danvo/Baotai) — not fatal in absolute terms. The real watch points are the divergence between the Hundsun Cloud asset-group impairment-test assumptions (forecast-period revenue growth above +10%) and 2026H1 overseas revenue of -13.5%, as well as the RMB 2.86 billion of long-term equity investments on the books (the Yingshisheng stake posted its own net loss of RMB 79.33 million in 2026H1, Hundsun's equity-method share ~-RMB 18.65 million). If goodwill plus long-term equity investment impairments exceed RMB 200 million in the annual report, or Ant Fund net profit falls ≥30% YoY, the "cushion" judgment in this thesis must be downgraded.
| Metric (RMB 100M) | FY2023 | FY2024 | FY2025 | 2026Q1 | 2026H1 (latest period) |
|---|---|---|---|---|---|
| Revenue | 72.81 | 65.81 | 57.83 | 9.05 | 21.44 |
| Revenue YoY | +11.98% | -9.62% | -12.13% | -11.75% | -11.65% |
| Net profit attributable | 14.24 | 10.43 | 12.31 | 1.39 | 2.61 |
| Attributable YoY | +30.50% | -26.75% | +18.01% | +342.87% | +0.06% |
| Adjusted net profit attributable | 14.48 | 8.34 | 10.13 | ~0.73 (est.) | 2.08 |
| Adjusted YoY | +26.51% | -42.39% | +21.46% | — | +8.37% |
| Gross margin (main business) | 74.85% | 72.05% | 71.06% | — | 69.40% |
| Net margin (attributable) | 19.56% | 15.85% | 21.29% | — | 12.16% |
| Operating cash flow | 12.61 | 8.68 | 10.67 | -11.6 | -9.82 |
| Free cash flow | 3.57 | 4.52 | 8.27 | — | Seasonally distorted |
| Cash-like assets (end of period) | — | 47.42 | 55.38 | — | 40.39 |
| Interest-bearing debt (end of period) | — | — | 4.48 | — | 4.67 |
| Net cash (end of period) | — | — | 50.90 | — | 35.72 |
| Debt-to-asset ratio | — | — | 32.47% | — | 29.09% |
Note: 2026Q1 adjusted profit is an estimate of attributable profit of RMB 139 million less non-recurring gains/losses of RMB 66 million; cash-like assets = cash + trading financial assets + time deposits + other debt investments, etc. (consistent scope across periods); net cash / interest-bearing debt / debt-to-asset ratio are stock figures, latest period based on the 2026-06-30 balance sheet. As financial IT is asset-light, net debt/EBITDA is not applicable (net-cash position).
Reasons for metric changes (items with YoY ≥±20%, all with company explanations): ① FY2024 adjusted profit -42.39%: the company attributed it to "negative growth in technology spending at some financial institutions, with widespread declines in IT budget execution rates… procurement initiation, procurement decision-making, and acceptance processes all significantly lengthened"; ② FY2025 investment income +169.32% to RMB 526 million: "mainly due to increased profits from associates and increased gains from disposals of equity investments in associates" (Ant Fund FY2025 net profit RMB 1.085 billion; disposal gains of RMB 199 million were one-off); ③ FY2025 three expense lines -21.72%/-18.99%/-11.33%: "mainly due to lower staff compensation costs this period" (headcount 13,189 → 10,276; severance benefits RMB 49.92 million); ④ 2026Q1 attributable profit +342.87%: "mainly due to increased investment income and fair-value gains vs. the same period last year"; ⑤ 2026H1 enterprise/insurance/fund software -35.83%: "mainly due to a relative decline in commercial paper business, plus the impact of revenue recognition timing"; wealth technology -23.48%: active contraction of the banking comprehensive wealth-management business and revenue recognition affected by project cycles, but contract liabilities grew significantly.
2026H1 revenue was RMB 2.144 billion (-11.65%), the third consecutive reporting period of double-digit decline, but the decline is no longer widening (Q1 -11.75% → H1 -11.65%); attributable profit RMB 261 million (+0.06%), adjusted profit RMB 208 million (+8.37%) — positive profit growth was almost entirely driven by Ant Fund equity-method income (~RMB 290 million) and expense compression; excluding equity-method income, core-business adjusted profit was ~-RMB 70 million, turning negative YoY (vs. ~+RMB 97 million in 2025H1). Operating cash flow was -RMB 982 million, an outflow RMB 81 million larger YoY, of which RMB 286 million was payment of previously accrued land appreciation tax (Qiantang Science & Technology Park final payment, one-off); excluding this, it is consistent with the seasonal pattern (outflows in Q1–Q3, concentrated collections in Q4). Order-side signals are mixed: contract liabilities of RMB 2.587 billion, +15.4% YoY but -2.9% vs. the start of the year. The 2026Q1 attributable profit of RMB 139 million (+342.87%) was driven by investment income and fair-value changes, with non-recurring gains of RMB 66.27 million — not representative — and the company itself cautioned that "Q1 results account for a relatively low share of the full-year total… and do not represent the company's full-year business trajectory" (90.3% of FY2025 adjusted profit was recognized in Q4). Market reaction: after the semi-annual report release (2026-08-25), Soochow Securities cut its 2026–2028 attributable profit forecasts the next day to RMB 1.3/1.7/2.3 billion (from RMB 1.5/2.0/2.6 billion); consensus was revised down -12.8% over the past 90 days, with the stock digesting via a slow decline.
Business model snapshot: Primarily financial IT product licensing (License) plus project-based delivery, transitioning toward subscription/SaaS (management describes it as "shifting from hunting to farming"; subscription revenue +14.57% in 2026H1, with no disclosed subscription revenue share target). Customers are licensed institutions—securities firms, fund managers, banks, insurers. Core trading, TA registration, and valuation systems are "non-stoppable," creating extremely high switching costs; the top five customers account for only 4.97% of revenue—highly fragmented. Asset-light: the largest cost is personnel (R&D staff are 53.2% of headcount). FY2025 R&D spending was RMB 2.18 billion, a 37.70% expense ratio, fully expensed. Pricing power signal is negative: annual gross margin on core business declined consecutively from 74.85% to 71.06%; profits were defended by shrinking low-margin businesses and mix optimization, not by raising prices to customers.
Cash content of earnings: OCF/net profit attributable to parent for FY2023–FY2025 was 0.89/0.83/0.87—persistently below 1 but acceptable, mainly due to Q4-concentrated acceptance/receivables seasonality. FCF/net profit attributable was 0.25/0.43/0.67; FY2023–2024 was swallowed by Qiantang Science Park CapEx (RMB 905 million / 416 million). After the park's peak, FY2025 CapEx fell to RMB 239 million (CapEx/D&A about 1.35x; maintenance vs. growth split not disclosed), with FCF quality clearly recovering. Recurring earnings test: FY2025 net profit attributable of RMB 1.231 billion vs. non-GAAP (recurring) net profit of RMB 1.013 billion—a gap of RMB 218 million, mostly a one-off gain of RMB 199 million from disposals of long-term equity investments. More critically, recurring earnings include about RMB 260 million of equity-method income from Ant Fund (recurring but not core-business controllable)—"recurring core-business profit" is only about RMB 750 million, or 61% of reported net profit attributable. Reverse-approach check: the company makes no aggressive Non-GAAP adjustments; fully expensing R&D is actually conservative. But the effective tax rate is only 1.32% (VAT refund-upon-collection of RMB 168 million + R&D super deduction of RMB 151 million); tax incentives contribute about RMB 320 million of profit support, and policy rollback is a hidden risk.
Return on capital: ROIC about 11.6% (FY2025, NOPAT/invested capital), above WACC (about 9%) but below the 15% strong-moat line; excluding about RMB 6.2 billion of wealth-management products/financial assets, operating capital returns are significantly higher. ROE 17.4%/19.2%/12.5%/13.3% (2022–2025)—stabilized after stepping down.
Quality red flags: ① Growing dependence of profit on investment income (2026H1 investment income/total profit 116.8%); ② RMB 4.04 billion of cash-like assets largely allocated to wealth-management products and time deposits rather than core-business reinvestment—mirroring core business contraction; ③ supplier concentration with related parties (top five suppliers 28.28%, of which related-party purchases are 16.5%, mainly Ant-affiliated cloud and ecosystem); ④ continued impairments of associate/incubated assets (see chapter "Financial Engineering and Cross-Period Consistency"). Overall judgment: about 60% of book profit converts to freely disposable cash (FCF/net profit 0.67 and improving), but about 40% of "profit" itself does not come from core-business operations.
Words vs. deeds: partially delivered. ① The FY2024 annual report promised a 2025 "steady cash flow and profit strategy, higher per-capita revenue and per-capita profit"—OCF +22.91% and recurring net profit +21.46% delivered; but per-capita revenue of RMB 562,800 fell 6.6% from RMB 602,300 in 2024—per-capita metrics not delivered. ② The FY2025 annual report promised growth in 2026 "net operating cash flow"—2026H1 net outflow widened by RMB 81 million YoY (improved after excluding a one-off land VAT item), pending Q4 verification. ③ Equity incentive assessment: all three exercise windows tied to the 2024 assessment "not met" and shares forfeited (August 2025 announcement); all three tranches tied to the 2025 assessment "met" (August 2026 forfeiture only for departures/performance)—incentive delivery shows a break followed by repair.
Shareholder friendliness: neutral to friendly. Cash dividend payout ratio 17.3% (FY2023) → 18.1% (FY2024) → 30.74% (FY2025, RMB 378 million), plus an interim 2026 dividend of RMB 0.5 per 10 shares (RMB 95 million, 36.29% of H1 net profit attributable); dividends plus cancellation-style buybacks over the past three years total roughly 85% of average annual net profit. No placements/rights issues/convertibles, no dilutive financing history. Deductions: the 2026 ESOP transfers 1.5465 million shares to ≤159 people at RMB 11.41/share (half the pre-draft average price of RMB 22.81; 30% of the RMB 37.46 repurchase cost), implying a transfer of benefits of about RMB 82 million—small in scale (0.08% of total shares) but aggressive in pricing. The 2026 options of 30.933 million units (1.63% of shares) have a strike of RMB 22.81, above the current price; dilution and expense (estimated RMB 50–60 million per year) need monitoring.
Risk signals: The company has no actual controller; Ant-affiliated Hundsun Group holds 20.79% (no pledge). The 2025 board reshuffle (Liu Shufeng stepped down; Peng Zhenggang became Chairman; 4 Ant-affiliated directors including Ant CEO Han Xinyi) means strategic continuity coexists with Ant ecosystem synergy/dependence. Related-party purchases of RMB 186 million/year require ongoing fairness-of-pricing checks. In investor communications, on core issues such as SaaS share and the second growth curve, the company only responded "thanks for the suggestion"—disclosure granularity falls short of market concerns.
FY2025 core business segments (revenue RMB 5.783 billion):
| Segment | Revenue Share | Gross Margin | FY2025 YoY | 2026H1 YoY | Business Logic in One Sentence | Gross Profit Pool Share (est.) |
|---|---|---|---|---|---|---|
| Wealth Technology Services | 22.8% | 73.19% | -7.72% | -23.48% | UF3.0 brokerage core + wealth management; active shrinkage of bank wealth-management projects | ~23.5% |
| Asset Management Technology Services | 21.8% | 78.43% | -19.82% | +2.58% | O45/O32 investment trading + Summit; Xinchuang batch delivery starting | ~24.1% |
| Operations & Institutional Technology Services | 21.9% | 77.99% | -1.82% | -10.55% | TA/valuation/PB systems; subscription pilot | ~24.0% |
| Corporate Finance, Insurance Core & Financial Infrastructure | 9.3% | 40.55% | -21.75% | -35.83% | Bills/treasury business shrinking; 2026H1 gross margin down to 22.23% | ~5.3% |
| Innovation Business | 8.5% | 77.56% | -4.85% | -1.78% | Yunyi (H1 net profit RMB 50.87 million), Hundsun Technologies (HK), Jinnna | ~9.3% |
| Data Services (Juyuan) | 6.1% | 62.46% | -0.47% | +9.82% | Financial data subscription 2.0; AI data demand; only core segment with positive growth | ~5.4% |
| Risk & Platform Technology Services | 5.8% | 58.01% | -32.33% | -17.14% | Data mid-platform actively shrunk; 2026H1 gross margin 42.43% | ~4.7% |
| Others (incl. property leasing) | 3.8% | 70.36% | -6.66% | — | Park property and miscellaneous | ~3.8% |
Profit engines: Estimating the gross profit pool via "revenue share × gross margin," three segments—Asset Management Technology (24.1%), Operations & Institutional (24.0%), and Wealth Technology (23.5%)—together contribute about 72% of gross profit—all three being standardized product lines with 73–78% gross margins. Asset Management Technology, at only 21.8% of revenue, is the single largest gross profit source, not Wealth Technology, the largest by revenue. Structural dispersion: the highest gross margin (Asset Management 78.43%) and the lowest (Corporate Finance 40.55%) differ by 37.9 percentage points, because the nature of the businesses differs—Asset Management/Operations are standardized products with "regulatory access + extreme switching costs," while Corporate Finance bills/treasury is project-based customization and channel-type business, from which the company is actively retreating (2026H1 gross margin of that segment already down to 22.23%). Marginal changes: the only core segment growing in 2026H1 is Data Services (+9.82%, AI data demand); Asset Management Technology turning positive (+2.58%) is the earliest signal of Xinchuang delivery starting; the shrinkage in Risk & Platform and Corporate Finance is active cleanup, but also drags total revenue.
Accounting red flags: ① One-off disposal gains lifting results: FY2025 gain on disposal of long-term equity investments of RMB 199 million, 15.3% of total profit—already excluded from the recurring basis, but the market often compares attributable profit, creating a base effect (severity: medium); ② consecutive impairments of non-goodwill assets: long-term equity investment impairments FY2025 -RMB 38.26 million / FY2024 -RMB 36.01 million (N2N, Fupu Gongjin, etc.); intangible asset impairment FY2024 -RMB 18.39 million—continued cleanup of poorly returning M&A and incubated assets (medium); ③ goodwill impairment and key audit matters: FY2025 impairments were Shanghai Jinna (RMB 28.45 million), Danwo Intelligence (RMB 18.38 million), Hundsun Baotai (RMB 9.54 million); FY2025 Hundsun Technologies RMB 9.97 million + Summit first-time RMB 12.74 million; cumulative impairment allowance RMB 301 million against a gross carrying value of RMB 922 million (low); ④ normalized software-project inventory write-downs: FY2025 -RMB 33.77 million / FY2024 -RMB 28.63 million; inventory balance rose to RMB 823 million in 2026H1 (+21.5%), sinking costs of customization projects rising (low).
Cross-period consistency: ① Core-business gross margin: annual 74.85% → 72.05% → 71.06% declining; 2026H1 same-basis 69.40% (-0.16pct YoY)—consistent with management's explanation of "revenue and cost matching"; ② three consecutive periods of negative revenue growth: FY2024 attributed to lower budget execution rates and lengthening processes; FY2025/H1'26 attributed to active shrinkage + industry contraction—narrative coherent and corroborated by external evidence (industry-wide declines)—consistent; ③ headcount 13,189 → 10,927 → 10,276 (-22.1%): severance benefits of RMB 49.92 million corroborate compensated layoffs; 2026H1 admin expenses turned +3.0% due to compensation—compression dividend nearing its end—consistent; ④ Q4 concentration: Q4 revenue share 39.7% (FY2025); Q4 attributable profit 63.0% and recurring profit 90.3% of full year—stable acceptance-driven pattern; company has flagged seasonality—consistent; ⑤ profit structure (investment income + fair value changes / total profit) is highly volatile and exceeded 100% in 2026H1; the company explained each item's change but did not respond to the rising dependence—company did not explain; this is the cross-period issue this report watches most closely.
Current market data: Share price RMB 20.84 (2026-10-26 close), market cap RMB 39.53 billion. PE (TTM attributable) 32.1x (1/3/5/10-year percentiles 28%/33%/20%/10%), recurring basis 38.4x, PB 4.07x (4% percentile over 10 years), PS 7.19x, dividend yield about 1.2%. Earnings are in an early stabilization after a decline, and attributable profit includes large investment income—PE/PB percentiles are for reference only, not headline expensiveness signals; the more informative lens is forward: 2026E consensus forward PE 29.1x, 2027E 25.0x; PEG about 2.9 (at consensus +10% growth)—if one accepts Soochow's 2026–2028 attributable profit CAGR of about 33%, PEG is about 0.9. The divergence between these two readings is itself the "recovery slope" debate.
Peer comparison (2026-10-26):
| Company | PE (TTM) | PB | FY2025 Revenue Growth | ROE (FY2025) | Key Difference |
|---|---|---|---|---|---|
| Hundsun Technologies | 32.1 (recurring 38.4) | 4.07 | -12.13% | 13.3% | B2B financial IT leader; subject of this report |
| Apex Software | 29.55 | 4.02 | -12.38% | ~12% | Challenger to smaller brokers' new core systems; 2026H1 already positive (revenue +1.0%, attributable profit +36.3%) |
| Hithink RoyalFlush | 38.88 | 18.25 | +44.0% | 36.7% | C-end traffic + AI; benefits from retail activity; far more elastic than B2B |
| 财富趋势 (Tonghuashun wealth trend / Guide Investment) | 88.73 | 6.96 | -5.37% | 8.5% | Lean headcount; 85%+ net margin relying on wealth-management product income; structure not comparable |
| KINGDOM | Losses, PE meaningless | 2.81 | -48.46% | -4.65% | Sharper contraction; asset-floor reference |
Market-implied expectations: Market cap RMB 39.53 billion ÷ 35x (about 10% discount to the peer median of 38.9x; anchor independent of the company's own current price; for reference, the company's 2021–2023 boom-period forward midpoint was about 45x and its 2024 trough TTM about 24.5x) = implied 2026 recurring net profit of about RMB 1.13 billion (+11.5%)—i.e., "the current price requires the company to deliver 11.5% recurring growth in 2026, while H1 actually delivered only +8.4%, and that includes the Ant Fund contribution." Sensitivity: valuing Ant Fund at 20x FY2025 profit (about RMB 5.2 billion) implies core-business recurring profit of RMB 880 million (+17% vs. FY2025 core of RMB 750 million); at 2026 annualized profit (about RMB 11 billion), implied core recurring profit is only RMB 710 million (-5%)—the price the market pays for the core business sits between "negative growth" and "modest recovery," with the midpoint pinned at the incentive-assessment threshold.
Three-layer value (EPV): Asset value about RMB 2.94/share (net cash 1.88 + long-term equity investments at book 1.39 − goodwill 0.33; an independent floor reference); EPV with zero growth about RMB 9.1/share (this report's calculation: normalized core FCFF of RMB 0.41/share ÷ 9% + net cash and Ant stake of RMB 4.56/share; range RMB 8.5–9.7). The gap between the current price of RMB 20.84 and EPV is about RMB 11.7—the growth option accounts for about 56% of the current price—more than half of the market's pricing rests on "Xinchuang delivery + subscription/AI transformation + Hundsun Technologies ramp-up." That option has a genuine industrial window (management has flagged 2026–2027 as critical; UF3.0/O45 orders in the pipeline), but per this report's calculation, a 56% option weight is not small—one cannot conclude "the market is paying only for zero growth"; the conclusion is the opposite: the current price is a mid-sized bet on recovery. EPV is a floor, not a final verdict: if core revenue keeps falling at double digits, the normalized cash flow base itself will shift down.
Three scenarios and odds:
| Scenario | Probability | Fair Range (RMB) | vs. Current | Decisive Factors |
|---|---|---|---|---|
| Bear | 20% | 11.5–13.5 (midpoint 12.5) | -40% | Revenue down another 5–10%, recurring profit below RMB 800 million, price war compressing gross margin to 66%, Ant Fund declining—core 650 million × 25x + net cash 3.57 billion + Ant at 15x |
| Base | 50% | 19.1–21.6 (midpoint 20.35) | -2.4% | 2026 recurring profit 1.05–1.15 billion (at the assessment threshold), revenue turning positive in 2027, flat expenses—core 800–930 million × 35x + net cash + Ant at 20x − goodwill |
| Bull | 30% | 28–31 (midpoint 29.5) | +41.6% | Xinchuang + AI ramp-up, 2027 revenue +8%, recurring profit back to ~RMB 1.3 billion, subscription share breakthrough—2027E core 1.05 billion × 45x (boom-period anchor) |
Probability-weighted fair value about RMB 21.5 (+3.3% vs. current)—the current price sits slightly below the distribution midpoint; odds roughly symmetric, tilted slightly upward. Note on the asymmetry of the distribution: the bear-case midpoint of RMB 12.5 implies a PB of about 2.44x, below the current 4.07x already at a 10-year 4% percentile—the bear case requires "valuation at a ten-year low + double-hit to earnings" simultaneously, hence 20% probability rather than higher. The bull case of RMB 29.5 is close to the most bullish sell-side (Guotai Haitong RMB 32.06, 43x × 2026E attributable profit of RMB 1.412 billion). External anchors: the most pessimistic sell-side is Soochow at 2026 attributable profit of RMB 1.3 billion (a 13% cut from its prior estimate, still Buy)—its earnings assumption sits above this report's bear case; this report's bear case is built on independent stress assumptions and does not adopt the sell-side floor as a boundary; the lowest sell-side target of RMB 17 is also above this report's bear-case upper bound, the difference arising from this report's double compression of 15x on Ant Fund and 25x on the core business.
Own earnings forecasts (reconciliation anchor): FY2026 revenue RMB 5.23–5.50 billion (-9.5%~-4.9%), attributable profit RMB 1.18–1.40 billion, recurring profit RMB 1.03–1.15 billion; FY2027 revenue RMB 5.55–6.05 billion (+3%~+9%, turning positive), attributable profit RMB 1.30–1.60 billion, recurring profit RMB 1.15–1.35 billion. The midpoints are below Soochow (1.3/1.7 billion) and Guotai Haitong (1.412/1.628 billion), mainly because we assume revenue turns positive only in 2027 and extrapolate Ant Fund conservatively post-fee reform. Against management's own yardstick: the incentive assessment thresholds are 2026 recurring profit ≥ RMB 1.115 billion and 2027 ≥ RMB 1.226 billion (broad basis including equity-method income)—our range straddles the threshold; whether it is met hinges on Q4 (H2 needs RMB 906 million, +10.4% YoY).
Conclusion: Fairly valued (fair). Quality (net cash + Ant stake + a 71%-gross-margin product matrix + two consecutive years of recurring profit growth) and price (implying +11.5% recovery; 56% growth-option weight) roughly offset each other; the target range of RMB 19.1–21.6 is the base-case fair value; the current price is 2.4% above the base midpoint, and the base-case lower bound is 8% below the current price (negative margin of safety)—no margin of safety. Wait for right-side signals before adding: any one of a single-quarter revenue turn to positive, contract liabilities rising sequentially, or meeting the assessment threshold.
Industry Size. Hundsun Technologies operates in the "capital markets-side B2B" segment of China's financial IT solutions market, a fundamentally different business from retail-facing brokerage IT (Tonghuashun/Tongdaxin). Market size by scope: ① Banking IT solutions at RMB 71.45 billion in 2025 (IDC), up only +0.2% YoY (RMB 71.305 billion in 2024)—falling from high growth into a "low-speed, high-quality" stock phase; ② Securities industry IT spending: the SAC requires "no less than 7% of revenue"; based on estimated 2025 brokerage revenue of RMB 541.171 billion, that implies roughly RMB 37.9 billion (calculated estimate, not official statistics; official figures: RMB 30.36 billion in 2021; RMB 28.11 billion combined across 44 disclosing brokers in 2023); ③ China's financial-sector generative AI investment at RMB 8.968 billion in 2025, with IDC forecasting RMB 44.519 billion by 2029, a CAGR of ~49.3%—the only high-growth track in the industry (note the narrow scope: "platform and application solutions" were only RMB 914 million in 2024, not directly comparable); ④ Financial cloud market at RMB 38.01 billion in 2025H1, +20% (IDC). Banking IT 2024–2029E CAGR of 7.8% (IDC, RMB 103.9 billion in 2029). Hundsun's 2025 revenue was RMB 5.783 billion—deeply penetrated in the capital-markets segment, shallow in banking.
Value Chain and Value Distribution. Upstream is software labor (the largest cost item; 5,463 R&D staff, 53.2% of headcount), servers/databases/middleware (Xinchuang adaptation to the Kunpeng/Hygon/openGauss ecosystems)—supply is abundant and bargaining power weak, but Hundsun's top five suppliers account for 28.28% of procurement, including related parties (Ant-affiliated cloud and ecosystem) at 16.5%, implying ecosystem lock-in. The midstream is solution vendors, where profitability is determined by productization rates—Hundsun's gross margin is 71.06%, Apex's ~71, Kingsware's only 39.26% (dragged down by distribution/integration); gross profit clearly accrues to the "standardized core product" segment. Downstream are brokers (~150), public funds (AUM of RMB 37.71 trillion, +14.9%), bank wealth management, insurance asset managers, and exchanges; Hundsun's top five customers account for only 4.97%—highly dispersed. Hundsun has strong bargaining power over upstream, and against downstream it maintains its 71% gross margin through mission-critical "cannot-go-down" systems such as trading/TA/valuation. However, from 2025 onward, public fund fee reform has compressed client profits → shrinking budgets → marginally stronger buyer bargaining power, manifesting as consecutive revenue declines with only slight margin erosion—the company offsets this by cutting delivery costs through "separating product development from delivery."
Supply, Demand, and Competitive Structure. Four demand drivers: capital market activity (2025: A-share total market cap exceeded RMB 100 trillion; broker revenue +19.95%/net profit +31.2%), institutional expansion, regulatory upgrade as rigid demand (Xinchuang full replacement by 2027/core-system single-track by 2028, new programmatic trading rules, SM-cryptography conversion), and AI large models (financial GenAI CAGR ~49%). On the supply side, B2B core systems are an oligarchic hierarchy: the new broker core is "a four-way split"—Hundsun UF3.0, Huhulian (H brokerage) ATP... specifically Hundsun's UF3.0, Hrzq's ATP, Kingsware's FS2.5, and Apex's A5. For fund/insurance/trust investment-trading systems and securities centralized trading systems, a 2019 Huatai Securities research report put Hundsun's market share at over 85% and ~50% respectively (Note: this is end-2016 data; the company's 2025 annual report only qualitatively states "relatively high market share," and the latest precise figures were not obtained—the two data points are presented side by side to avoid misreading). Banking IT concentration has long been low (China DZH has led eight years running). Barriers to entry: extremely high core-system switching costs (trading system failure = regulatory incident), industry know-how plus regulatory acceptance requirements, R&D scale thresholds (Hundsun's annual R&D spend of RMB 2.18 billion is 3–20x peers'), and customer trust (from the annual report: clients must believe a vendor "can survive long enough" before placing orders). Current supply-demand shows structural bifurcation of "traditional oversupply, emerging scarcity": traditional software procurement is a buyer's market (banking IT +0.2%, Hundsun -12.1%, Kingsware financial business -22.1%, Apex -12.4%), while AI and Xinchuang segments see local supply shortages. New supply comes from brokers' fintech subsidiaries' in-house development and cloud vendors/large-model companies entering peripheral scenarios via API/Agent models.
Quantified Chain of the AI Demand Inflection. Financial GenAI investment: RMB 8.968 billion (2025) → RMB 44.519 billion (2029E, IDC); 65% of financial institutions were already using large-model platforms/tools in 2025. But increment and crowding-out coexist, both with hard data: On the increment side—financial agent industry bid wins of ~RMB 103 million in August, 5x July's level (Zero One Think Tank); Hundsun won 2 bids in that single month, and CCB's Zhejiang branch made a sole-source procurement of WarrenQ; in October, Zheshang Bank's agent procurement of RMB 64.8961 million set a new single-deal record for the year. On the crowding-out side—top brokers' total IT spending still grew positively in 2025 (Huatai RMB 2.679 billion +9.43%, Zhongtai RMB 1.694 billion +11%, GF RMB 1.548 billion +12.41%), while third-party software vendors' revenue broadly declined—the total pie is growing, but flows to in-house development/AI infrastructure/Xinchuang hardware, structurally crowding out purchased traditional software; this is the industry-level attribution for Hundsun's 2026 valuation compression. Hundsun's AI revenue is not separately disclosed; AI increments are not yet enough to offset traditional contraction (2026H1 revenue still -11.65%). Core trading/clearing/TA and other heavily regulated segments cannot be replaced by general-purpose large models in the short term (annual report: "financial systems reject machine hallucinations"); replacement risk is concentrated in peripheral scenarios (investment research/customer service/reporting). Judgment: for Hundsun, AI brings "structural increment + short-term crowding-out" simultaneously; the net-effect inflection has not arrived.
Cyclicality and Regulation. Financial IT spending lags downstream profit cycles by 1–2 years; the industry is currently in a transition-bottoming phase of "traditional procurement declining, AI + Xinchuang rising." Leading indicators: broker revenue/net profit (strong 2025 but not yet transmitted), absolute IT spending at top brokers (still growing), public fund AUM, Xinchuang tender cadence, and Hundsun's contract liabilities (+15.4% YoY). Key policies: ① The three-phase public fund fee reform concluded (September 2025 new rules on sales fees, yielding over RMB 50 billion annually to investors, directly compressing fund companies' IT budgets; Hundsun's annual report explicitly notes client spending shifting "from broad and comprehensive to focused and refined"); ② the "Three-Year Securities Industry Network and Information Security Improvement Plan (2023–2025)": IT spending ≥ 10% of average net profit or 7% of revenue—the demand foundation; ③ the Xinchuang timetable: all systems Xinchuang-compliant by 2027, core systems on single-track operation by 2028 (per regulatory requirements cited by Hundsun's chief architect), with 2025–2027 the peak of core replacements; ④ new programmatic trading rules (futures detailed rules effective October 2025, northbound reporting effective January 2026) driving risk-control/ultra-fast-trading compliance upgrades—LDP ultra-fast risk control is already live at multiple brokers. Net effect: fee reform suppresses existing License revenue, while Xinchuang and programmatic-trading rules create rigid upgrade demand; the outcome hinges on whether increments can outweigh decrements.
Company Positioning. Hundsun remains the absolute leader in China's capital-markets IT (2025 revenue of RMB 5.783 billion—3.2x Kingsware's financial business and 10x Apex's), but its position is being eroded from two fronts: revenue has declined for two consecutive years, and in 2025 Tonghuashun (RMB 6.029 billion) overtook it, stripping away the title of "No. 1 in securities IT revenue." Its share is declining in the traditional License metric but holding in new core systems (UF3.0 signed 25 new clients within the year, O45 in batch delivery, next-gen TA/valuation/operations adding 270+ new clients) and the Xinchuang metric. The three pillars of its moat remain solid: extreme switching costs of core systems, productization capability of a full product matrix + 71% gross margin (R&D intensity 3–20x peers'), and 30 years of customer trust and data know-how. Industry consolidation (exit of small/mid-tier vendors, easing of vicious price wars) actually benefits the leader's market share.
A generic framework easily misses the four defining dimensions of this industry; listed separately:
1. Extreme Seasonality of Revenue Recognition—Q4 is everything: In FY2025, Hundsun's Q4 revenue was 39.7% of the full year, attributable profit 63.0%, and non-GAAP (adjusted) profit 90.3%. Any conclusion extrapolating full-year results from Q1–Q3 standalone quarters carries huge error (non-GAAP profit for the first three quarters of 2025 was only RMB 99 million, versus RMB 914 million in Q4 alone). This also sets the interpretive discipline for the 2026-10-31 Q3 report—the focus is not headline growth (high growth on a low base is inevitable), but whether contract liabilities and Q3 standalone non-GAAP profit turn positive (Q3 2025 standalone: approximately -RMB 93 million).
2. Contract Liabilities Are a Leading Order Indicator—But Compare on a Like-for-Like Basis: Contract liabilities: FY2023 end RMB 2.174 billion → FY2024 end RMB 2.527 billion → FY2025 end RMB 2.665 billion → 2026H1 end RMB 2.587 billion. The +15.4% YoY supports the order-improvement narrative; the -2.9% decline versus the start of the year weakens it—the interim report notes show RMB 971 million of revenue was recognized from opening contract liabilities this period, depleting faster than replenishing. The truth awaits the Q3/Q4 year-end figures: if year-end contract liabilities set another multi-year high, then "orders lead" holds; if they stay flat sequentially, Xinchuang demand is more of a "new replacing old" stock replacement.
3. The Subscription Transition Is the Key to Switching the Valuation Anchor: Management frames it as "switching from hunting to farming" (project-based hunting → subscription-based farming); in 2026H1 subscription revenue grew +14.57%, TA/valuation/operations began subscription pilots, and Juyuan Data 2.0 moved to subscriptions. But the company does not disclose subscription revenue share or targets—the transition's progress cannot be quantitatively verified; this is a question management dodged when pressed (the SSE e-interaction platform only replied "thanks for the suggestion"). If the subscription share shows verifiable improvement over the next two annual reporting cycles, revenue volatility declines and there is room for the valuation anchor to shift from project-based ~30x toward subscription software 40x+; otherwise, the "transition" is merely a narrative.
4. Per-Capita Productivity and R&D Ratio Are the Entire Source of Profit Elasticity: R&D-to-revenue ratio 36.55% → 37.36% → 37.70% (FY2023–2025), all expensed—the absolute R&D spend (RMB 2.18 billion) means only the leader can afford a full product matrix; revenue per employee RMB 552,100 → 602,300 → 562,800, with FY2025 declining as revenue fell faster than headcount; in 2026H1, administrative expenses already turned +3.0% due to compensation. The cost-compression dividend is nearing its end; 2027 non-GAAP growth must find a new engine (revenue). Outsourcing backfill (2025: 21,491 person-months of labor outsourcing, RMB 406 million) mirrors headcount contraction; the productivity strain during UF3.0/O45 batch delivery warrants monitoring of delivery quality.
Overall Rating: Neutral (confidence 0.55, 6–12 months). Hundsun's balance sheet (net cash of RMB 3.57 billion plus Ant Fund equity) and product moat (71% gross margin, core-system positioning) provide a genuine floor, but the fact that core-business revenue has declined for three consecutive years while profits rely on non-core pillars defines this as a "good company, weak present, fairly priced" target: the current price of RMB 20.84 already prices in recovery to the incentive-assessment threshold; the probability-weighted fair value of ~RMB 21.5 is only 3.3% higher, while the base-case fair-value floor sits 8.4% below the current price—the odds do not support heavy left-side positioning.
Strategy: Holders can keep holding pending Q4 validation; incremental capital should wait for right-side signals—① Q4 2026 or any single quarter of 2027 with YoY revenue turning positive; ② contract liabilities rebounding sequentially in the Q3 report/annual report and setting a multi-year high; ③ the 2026 annual report confirming incentive-assessment targets met (non-GAAP profit ≥ RMB 1.115 billion). Any one confirmed, the door opens for re-rating toward the base-case upper bound–bull case range (RMB 21.6–29.5).
Risk and Catalyst Notes: Downside—core-business contraction exceeding expectations (Q3 non-GAAP/contract liabilities falsified), Ant Fund earnings weakening with markets (attributable profit elasticity on the order of -9%), price wars compressing gross margin below 67%, goodwill + long-term equity investment impairments exceeding RMB 200 million, tax incentive phase-out (extreme case ~ -RMB 280 million/year); Upside—batch Xinchuang core-system acceptance (UF3.0/O45), replication of WarrenQ and other agent subscriptions, the Hong Kong financial exchange platform pilot in 2027Q1, confirmation of incentive-assessment targets met. Technical reference: 52-week low of RMB 18.83 (-9.6% from current price) as key support; option exercise price of RMB 22.81 (9.5% above current price) as overhead resistance and an interest-alignment line.
This report's price anchor is the 2026-10-26 closing price of RMB 20.84 (frozen basis); PE/PB percentiles, consensus estimates, and peer multiples in the report are all time-stamped. Data sources: company periodic reports and announcements (cninfo/SSE), SSE e-interaction, East Money consensus estimates, IDC, Zero One Think Tank, Cailian Press, etc.; see the list of evidence and key quotations for details.